1. Home
  2. Companies
  3. Radical Ventures
RV

Radical Ventures

About

Like Benjamin Franklin knotting a key to a kite in a lightning storm, today’s AI researchers are unlocking technology that is reshaping our world.

From quantum neural networks and transformers for NLP, to AI for drug discovery, the path to future innovations and commercialization is charted by a small subset of the global technology talent pool, the elite AI researchers. Coalescing around the pioneers of AI, including Toronto’s “godfather of deep learning” Geoffrey Hinton, this AI talent pool has laid the foundations for innovation and rapid commercialization.

Radical is both a product of the Canada AI ecosystem and one of its architects. Radical founders Jordan Jacobs and Tomi Poutanen helped co-author the world’s first national AI strategy and conceived of and co-founded the Vector Institute for Artificial Intelligence, alongside Geoffrey Hinton, Ed Clark and others in 2017. Vector began with 8 faculty and is now home to over 1700 of the world’s top AI researchers. Before Radical, Jordan and Tomi founded Milq in 2011 and then spun-out Layer 6 AI in 2016, an AI prediction platform company later acquired by TD Bank, where they became co-Chief AI Officers. As founders, ecosystem builders and investors, the Radical team has played an active role in nurturing the next generation of AI innovation and commercialization.

Just as Thomas Edison would build upon Franklin’s discoveries, now is the moment to capitalize on the opportunity afforded by innovations in AI. Every facet of our economy and lives stand to benefit from breakthroughs in AI. Like today’s electrical grid, AI will soon power nearly every human interaction with technology.

Lightning to light bulb. That is the transformative moment we are investing in.

Similar companies

BV

BioGeneration Ventures

We are a venture capital firm specialised in seed investment for innovative early stage companies. BGV generally acts as lead investor. Our team is made up of life science experts and business analysts that can guide life science companies’ development throughout the entire research and development process. BioGeneration Ventures leverages its knowledge gained from working with a diverse network. This includes universities, early stage biotech companies and large pharma. We enable a range of sector-relevant expertise to build and accelerate product development and transform entrepreneurs and their companies to become attractive investment opportunities within the life sciences industry. Our Strategy BioGeneration Ventures (BGV) was launched in 2006. We manage over EUR 250 million across four funds. BGV invests in medical and healthcare innovations that have high potential to positively impact patients. BGV works with an ethos founded in sound novel science. We seek those innovations that have a truly differentiated scientific basis, supported by convincing experimental data. These innovations must be compelling and stand out in the global scientific arena. Only innovations that can address a significant unmet medical need are considered for investment. We aspire to invest in solutions that provide substantial healthcare impact. Progressing a project from discovery to clinical proof-of-concept requires a breadth of experience that founding teams usually do not have from the outset. Through our extensive network and experience we help founders build their companies to extend their capabilities. We guide our portfolio companies along their journey from the scientific discovery to a targeted product development track. Together with the founders, we seeks to shape the companies and define the objectives that enable a successful exit. Our partnerships BGV invests in partnerships with other professional investors in life sciences and has built relationships with various academic institutions (such as Leiden University), venture capital investors in the Netherlands, the EU and the US. Forbion: BGV operates a joint venture partnership with Forbion, a leading European life sciences venture capital fund. Mibiton: Mibiton provides loans to enable promising young life sciences companies to purchase equipment. BGV actively supports the investment activities with BGV Managing Partner Edward van Wezel serving as a member of the board. Our Investors: BGV has a broad investor base comprising private equity/wealth managers, pension funds, academic institutions, regional development funds and private investors.

MV

Mila Ventures

Mila Ventures is building the Venture Scientist platform: an integrated venture-creation engine designed to translate frontier AI research into world-class companies - rooted in Canada, built for the world. Mila Ventures operates within Mila, a prestigious AI research institute based in Montréal, founded by Yoshua Bengio, one of the godfathers of modern artificial intelligence and a pioneer of deep learning. The platform brings together: Mila Venture Studio (co-creating companies with professors, students, and entrepreneurs) Mila Accelerator (early company building and scaling) Venture Scientist Academy (training researchers to become venture builders) The Mila Venture Fund (in formation) We operate at the intersection of AI research, venture creation, and capital, working closely with Mila's globally renowned researchers, students, founders, investors, corporate partners, and public institutions.

EF

Endless Frontier Labs

The EFL program runs from October – May each year. Founders are not required to have a New York University affiliation and do not have to relocate to New York. The program is free for founders – no equity or fees are taken. Other program benefits include: Executive mentorship: Business leaders, serial entrepreneurs, and seasoned executives will help you craft your company’s vision through time-bound, performance-based goals. Access to leading VCs and Investors: Investment mentors will guide you in successfully raising capital, make connections with New York’s investment community, and may even invest in your startup. Guidance from leading scientists: Prominent scientists and researchers across a myriad of verticals will help you mold your technology development strategy. Business development: NYU Stern’s MBA students will support you in a variety of ways based on your specific business needs. EFL team guidance: The EFL’s expert team will keep you on track to accomplishing your goals by optimizing your access to mentors, MBA students, and other resources throughout the program. Corporate services: EFL’s corporate partners donate many hours and hundreds of thousands of dollars worth of in-kind legal, financial, and technological services. Mentorship from business leaders and scientists Endless Frontier Labs’ mentors are business leaders, investors, and scientists drawn from New York’s thriving business and academic institutions and beyond. Our mentors commit substantial time to provide startups with the best advice and connections to maximize their chances of success. Our ValuesFounder Friendly: We are committed to provide programming in the long-term interests of entrepreneurs. We do not take equity or fees from startups. Each core aspect of the program is in the best interests of founders before, during, and after the program. Inclusivity: We are committed to building an inclusive, equitable, and just community now and for our future. We will provide an environment that is free of bias, prejudice, discrimination, and harassment. Performance Orientation: We are committed to (a) selecting founders with extraordinarily bold, new ideas, (b) providing intimate access to outstanding mentors, and (c) eliciting maximum effort from mentors and founders to accelerate the societal impact of breakthrough science.

PI

Panacea Innovation

Since its genesis at the University of Oxford in 2015, Panacea Innovation has partnered with some of the world’s best sci-entrepreneurs, research bodies, universities and corporates to build more than 280 companies that offer cutting-edge solutions - curating a portfolio of more than GBP£300m in value. Panacea Innovation’s venturing activities are delivered through two complementary arms: Panacea Stars - a technology translation, commercialisation and R&D arm - and Panacea Ventures, the investment management one.

FO

Frontline One Capital

We are at the forefront of revolutionary technologies disrupting industries and transforming human life at an accelerating pace towards singularity. Like the high-performance racing teams of Formula 1, we compete to lead premier investments in the world's most exceptional unicorns - hence «Frontline One»

QL

Quantum Light

QuantumLight is an investment firm built as a technology company by a team of tech unicorn founders, quant traders, AI scientists and engineers. We are using technology to disrupt the world of venture and growth equity. The industry is still stuck in the 20th century, operating in a completely different way from the technology companies it tries to support. Leveraging our experience building a hyper-growing unicorn and a background in quantitative trading, we are building the investment firm of tomorrow. A firm with a product DNA and a heavily data-driven investment strategy. We have already built and tested a first version of our proprietary data platform and decision engine, and we are currently in stealth mode, focusing on strengthening our team of elite professionals before public launch.